Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia

Selecting therapeutic products for the treatment of haemophilia follows the process of obtaining market approval of products submitted to the scrutiny of a regulatory agency. In well-resourced countries, key decisions on whether a product is sufficiently safe and of high quality are made by highly e...

Full description

Saved in:
Bibliographic Details
Published in:Blood Transfus
Main Authors: Farrugia, Albert, Liumbruno, Giancarlo M., Candura, Fabio, Profili, Samantha, Cassar, Josephine
Format: Artigo
Language:Inglês
Published: Edizioni SIMTI - SIMTI Servizi Srl 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6214824/
https://ncbi.nlm.nih.gov/pubmed/30201084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2018.0150-18
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items